OVERVIEW
Leishmaniasis is a group of diseases caused by parasites that spread through sandfly bites.
There are three main forms-the most common form affects the skin, causing ulcers that leave
permanent scars, often on the face and arms. These scars can cause stigma, especially for
women and girls. Another form affects the mouth, nose, and throat, destroying tissue and
causing severe disfigurement if left untreated. The most serious form attacks internal
organs like the spleen, liver, and bone marrow, causing fever, weight loss, and severe
anemia.
Without treatment, this form is almost always fatal. Leishmaniasis is one of the most
prominent neglected tropical diseases, affecting large numbers of people living in
impoverished areas where access to healthcare is limited. It is deeply linked to health
inequality, disparities in healthcare resources, and discrimination and prejudice.
MODE OF TRANSMISSION
Leishmaniasis spreads within a region through bites from sand flies that have become
infected after feeding on blood from reservoir animals, including humans. The sand fly is a
small insect measuring 2-3 mm in length, and is most active from dusk until dawn. When a
sandfly bites someone with leishmaniasis, it picks up parasites. The parasites develop
inside the sandfly, then spread to the next person the sandfly bites. Once in the body,
parasites invade cells and multiply. Depending on the parasite type and the person's immune
system, the infection may cause skin sores, spread to the mouth and nose, or travel to
internal organs. Many infected people never develop symptoms.
Sandflies breed in warm, humid places like cracks in walls, animal shelters, and piles of
organic material. People living in rural areas near sandfly habitats face the highest risk.
DISEASE BURDEN
Geographic scope:
- Almost all continents and tropical regions where the sand fly is found. Endemic in approximately 100 countries across the Americas, Africa, Asia, southern Europe, and the Middle East.
- The disease primarily affects remote rural populations, although some cases occur in cities.
- In 2023, Bangladesh became the first country to eliminate the serious form as a public health problem.
Population affected:
- More than 1 billion people live in areas where they could get leishmaniasis.
- Approximately 700,000 to 1 million new skin cases occur every year.
- An estimated 30,000-90,000 new internal organ cases occur annually.
- More than 12 million people are currently infected worldwide.
- Over 40 countries have reported cases in people also living with HIV, making treatment more difficult.
PREVENTION AND TREATMENT
Treatment depends on the form of disease, where the infection was acquired, and overall
health. The serious internal organ form requires medication given through IV or oral pills.
Common medications can cause nausea, vomiting, and kidney problems. Treatment cannot
completely remove the parasite from the body, so people with weakened immune systems may get
sick again. Some oral medications cannot be used during pregnancy because they cause birth
defects. Treatment effectiveness varies by region, with some areas showing resistance to
certain medications.
Prevention focuses on avoiding sandfly bites. Use insect repellent, wear long-sleeved shirts
and pants, and stay indoors from dusk to dawn when sandflies are most active. Sleep under
insecticide-treated bed nets and keep window screens in good repair. No vaccine is
available.
© Shota Koyano
Dr. Abhay Satoskar, the Ohio State University
Leishmania ethiopica, cutaneous form (ear)
Prof. Kenji Hirayama, Nagasaki University
Leishmania ethiopica, cutaneous form (right forearm)
Prof. Kenji Hirayama, Nagasaki University
* To provide a better understanding of the condition, this page features detailed clinical photographs.